Johnson & Johnson (JNJ) Enterprise Value (2009 - 2026)
Johnson & Johnson recorded quarterly Enterprise Value of -$22.1 billion in Q1 2026, down 9.7% quarter-over-quarter from -$20.1 billion in Q4 2025, and up 43.14% year-over-year from -$15.4 billion in Q1 2025.
Johnson & Johnson's Enterprise Value history runs 18 years deep, the most recent figure standing at -$22.1 billion for Q1 2026.
- In Q1 2026, Enterprise Value rose 43.14% year-over-year to -$22.1 billion; the TTM figure through Mar 2026 stood at -$22.1 billion (up 43.14% YoY), while the FY2025 annual figure was -$20.1 billion, up 18.02% from the prior year.
- Enterprise Value came in at -$22.1 billion for Q1 2026 at Johnson & Johnson, down from -$20.1 billion in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$18.6 billion in Q3 2025 to a low of -$38.8 billion in Q1 2025.
- A 5-year average of -$25.8 billion and a median of -$24.6 billion in 2023 frame the typical range for Enterprise Value.
- Across the five-year window, Enterprise Value slumped 47.92% in 2025 and surged 43.14% in 2026, its largest moves.
- Johnson & Johnson's Enterprise Value stood at -$34.1 billion in 2022, then jumped by 32.72% to -$22.9 billion in 2023, then dropped by 6.96% to -$24.5 billion in 2024, then climbed by 18.02% to -$20.1 billion in 2025, then declined by 9.7% to -$22.1 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$22.1 billion, -$20.1 billion, and -$18.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | -5.28 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | -22.05 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | -9.35 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -5.65 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | -12.04 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | -7.73 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -12.77 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -10.45 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | -4.68 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 29, 2026 | -22.05 Bn |
| Dec 28, 2025 | -20.10 Bn |
| Sep 28, 2025 | -18.56 Bn |
| Jun 29, 2025 | -18.88 Bn |
| Mar 30, 2025 | -38.78 Bn |
| Dec 29, 2024 | -24.52 Bn |
| Sep 29, 2024 | -20.30 Bn |
| Jun 30, 2024 | -25.48 Bn |
| Mar 31, 2024 | -26.22 Bn |
| Dec 31, 2023 | -22.93 Bn |
| Oct 1, 2023 | -23.51 Bn |
| Jul 2, 2023 | -27.25 Bn |
| Apr 2, 2023 | -24.61 Bn |
| Jan 1, 2023 | -22.28 Bn |
| Oct 2, 2022 | -34.08 Bn |
| Jul 3, 2022 | -32.57 Bn |
| Apr 3, 2022 | -30.39 Bn |
| Jan 2, 2022 | -31.61 Bn |
| Oct 3, 2021 | -31.00 Bn |
| Jul 4, 2021 | -25.31 Bn |
| Apr 4, 2021 | -24.62 Bn |
| Jan 3, 2021 | -25.19 Bn |
| Sep 27, 2020 | -30.78 Bn |
| Jun 28, 2020 | -19.14 Bn |
| Mar 29, 2020 | -18.02 Bn |
| Dec 29, 2019 | -19.29 Bn |
| Sep 29, 2019 | -17.95 Bn |
| Jun 30, 2019 | -15.28 Bn |
| Mar 31, 2019 | -15.34 Bn |
| Dec 30, 2018 | -19.69 Bn |
| Sep 30, 2018 | -19.36 Bn |
| Jul 1, 2018 | -18.14 Bn |
| Apr 1, 2018 | -15.20 Bn |
| Dec 31, 2017 | -18.30 Bn |
| Oct 1, 2017 | -16.23 Bn |
| Jul 2, 2017 | -12.85 Bn |
| Apr 2, 2017 | -39.34 Bn |
| Jan 1, 2017 | -41.91 Bn |
| Oct 2, 2016 | -40.43 Bn |
| Jul 3, 2016 | -42.58 Bn |
| Apr 3, 2016 | -39.86 Bn |
| Jan 3, 2016 | -38.38 Bn |
| Sep 27, 2015 | -37.31 Bn |
| Jun 28, 2015 | -33.95 Bn |
| Mar 29, 2015 | -31.32 Bn |
| Dec 28, 2014 | -33.09 Bn |
| Sep 28, 2014 | -33.01 Bn |
| Jun 29, 2014 | -31.62 Bn |
| Mar 30, 2014 | -29.39 Bn |
| Dec 29, 2013 | -29.21 Bn |
| Sep 29, 2013 | -25.23 Bn |
| Jun 30, 2013 | -25.13 Bn |
| Mar 31, 2013 | -21.67 Bn |
| Dec 30, 2012 | -21.09 Bn |
| Sep 30, 2012 | -19.77 Bn |
| Jul 1, 2012 | -16.92 Bn |
| Apr 1, 2012 | -33.85 Bn |
| Jan 1, 2012 | -32.26 Bn |
| Oct 2, 2011 | -30.93 Bn |
| Jul 3, 2011 | -29.68 Bn |
| Apr 3, 2011 | -26.87 Bn |
| Jan 2, 2011 | -27.66 Bn |
| Oct 3, 2010 | -22.13 Bn |
| Jul 4, 2010 | -18.90 Bn |
| Apr 4, 2010 | -18.01 Bn |
| Jan 3, 2010 | -18.84 Bn |
| Sep 27, 2009 | -14.34 Bn |
| Jun 28, 2009 | -14.72 Bn |
| Mar 29, 2009 | -12.59 Bn |